We retired this podcast, because we couldn't parse it for 10 consecutive times.
Date | Title & Description | Contributors |
---|---|---|
2020-01-15 |
Molecular Med Tri-Con 2020 | Artificial Intelligence in Precision Medicine Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s... |
|
2019-12-17 | Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and avail... |
|
2019-08-06 |
Immunogenicity Summit 2019 | From Cell & Gene Therapy to Biostatistics Nancy Sajjadi, an independent bioassay quality consultant with over 30 years of experience in biopharmaceutical product development, discusses her history in the bioassay field and how her experience has fostered her passion for teaching biostatistics ... |
|
2019-06-05 |
Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health. For more information, p... |
|
2019-03-26 |
the Liquid Biopsy Summit 2019 | Reimagining Liquid Biopsy Applications with Epigenomics Samuel Levy of Bluestar Genomics speaks to CHI on March 13, 2019. Dr. Levy will be speaking during The Liquid Biopsy Summit, June 17-19, in San Francisco, CA. Topics include cell-free diagnostics in precision medicine, transformation & growth in ... |
|
2019-03-05 |
Molecular DX Europe 2019 | Using Point-of-Care Diagnostics to Advance a One Health Approach Dr. Konstantinos Mitsakakis explains the One Health approach, and how the pursuit benefits diverse avenues of diagnostic research. For more information, please visit https://www.MolecularDXEurope.com/Point-of-Care-Dx |
|
2019-03-01 | Dr. Richard Levenson discusses the role of AI in digital pathology – what works, and what needs to be done for AI to reach its full potential. For more information, please visit https://www.TriConference.com/Digital-Pathology |
|
2019-02-18 |
Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient Harry Glorikian interviews Niven R. Narain about his approach on how to add more precision to the process of drug development and diagnostic development while engage more reproducibility. Niven also discusses how to use the biomarkers not only as a rea... |
|
2019-02-15 |
Molecular Med Tri-Con 2019 | Target the Tumor Mutational Burden and Pursue Harmonization Dr. Mark Stewart discusses the role of the tumor mutational burden (TMB) in cancer research and the need for harmonization throughout the process. For more information, please visit https://www.triconference.com/Companion-Diagnostics |
|
2019-02-08 |
PEGS Boston 2019 | Jennifer Chadwick’s Story of Building a Creative and Authentic Career in Science Dr. Jennifer Chadwick shares her journey from academia to industry, and the best advice that got her to where she is today. |
|